NFE2L2 and Insulin resistance: Pharmacological activation of Nrf2 by an acetylenic tricyclic bis(cyano enone), TBE-31, was also shown to reverse insulin resistance in obese mice, and to inhibit hepatic steatosis and fibrosis via suppression of endoplasmic reticulum, oxidative, and inflammatory stresses [155].